Related Experiment Videos
Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism
1Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden. g.hedback@home.se
Journal of Internal Medicine
|May 25, 2002
Summary
Patients with primary hyperparathyroidism and hypertension face higher cardiovascular death risks. Surgery improved survival, especially for hypertensive patients, indicating cardiovascular disease is integral to hyperparathyroidism.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Nephrology
Background:
- Primary hyperparathyroidism (PHPT) is linked to increased cardiovascular disease (CVD) mortality.
- Hypertension is a common comorbidity in PHPT patients.
Purpose of the Study:
- Compare post-surgical death risk in hypertensive versus normotensive PHPT patients.
- Investigate relationships between CVD, PHPT disease variables, and renal function.
Main Methods:
- Followed 845 PHPT patients (serum creatinine ≤160 µmol/L) for a mean of 10.2 years post-surgery.
- Utilized survival and correlation analyses; estimated death risk using Poisson hazard functions.
Main Results:
- Hypertensive PHPT patients had a 50% higher death risk than normotensive patients.
- Post-surgery, death risk decreased more rapidly in hypertensive patients.
- CVD correlated with serum calcium, adenoma weight, osteitis fibrosa, and serum creatinine; inversely with GFR and urine osmolality.
Conclusions:
- CVD is intrinsically linked to PHPT, related to serum calcium and adenoma weight.
- Decreased renal function is associated with CVD in PHPT.
- Surgical outcomes show a more pronounced survival benefit for hypertensive PHPT patients.